Elevance Health reported second quarter net income of $1.45 billion as medical costs fell in some health plans, triggering an improved outlook for the rest of the year.

This week’s Elevance Health and UnitedHealth Group quarterly earnings are much anticipated for signs health insurers are keeping a handle on rising costs.

Health insurers selling Obamacare are proposing another year of double-digit percentage premium increases for 2027, a new KFF analysis shows.

Cigna’s $100 million investment to support a new AI-powered pharmacy program and Peak Rock Capital’s purchase of Asembia may spur even more specialty pharmacy deals.

Peak Rock Capital bought Asembia, a provider of services surrounding specialty pharmacy including distribution, group purchasing and technology connecting patients.

Physicians are working harder for more pay amid an ongoing doctor shortage while reimbursement rates are stagnant and expected to worsen, a new AMGA report shows.

More mergers and acquisitions among pharmacy benefit management companies could follow the proposed combination of the PBMs Abarca Health and LucyRx.

Abarca Health and LucyRx – two independent pharmacy benefit managers – have agreed to merge asregulators and the public seek a better price on prescription drugs.

Obamacare insurer Centene is offering employees buyouts companywide to cut costs after losing more than two million health plan members this year.

Humana, one of the largest U.S. sellers of Medicare Advantage insurance for older adults, will divest its stake in a provider of end-of-life services for $900 million.